Editor claims drug companies have a "parasitic" relationship with journals

doi:10.1136/bmj.330.7481.9

BMJ 2005;330:9 (1 January), doi:10.1136/bmj.330.7481.9

News roundup

Editor claims drug companies have a "parasitic" relationship with journals

London Lynn Eaton

The relationship between medical journals and the drug industry is "somewhere between symbiotic and parasitic," according to the editor of the Lancet, Richard Horton. But at the moment it has swung too much towards the parasitic, he told the House Commons select committee on health last month in his oral evidence on the role of the industry.

He outlined some of the financial incentives that could, potentially, influence a commercially run medical journal to publish a paper. Many of the formal research papers in the Lancet are reprinted and bought in bulk by drug companies, which use them for marketing purposes, he explained. The drug companies regularly try to exert pressure on the journal to run a paper by arguing that, if the journal does so, they will buy reprints, which will earn the journal more money, he said.

He explained that the Lancet regularly gets . . . [Full text of this article]

Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to StumbleUpon StumbleUpon Add to Technorati Technorati What's this?

Rapid Responses:

Read all Rapid Responses

On 'conflict of interest': Astier M Almedom
bmj.com, 31 Dec 2004 [Full text]
"Fair is foul, and foul is fair": John Stone
bmj.com, 31 Dec 2004 [Full text]
"Fair is foul, and foul is fair" II: John Stone
bmj.com, 1 Jan 2005 [Full text]
"Fair is foul, and foul is fair" III: John Stone
bmj.com, 3 Jan 2005 [Full text]
yellow cards and industrial pressures: Nicholas D. Moore
bmj.com, 4 Jan 2005 [Full text]
Loss of integrity: Steve Hickey
bmj.com, 11 Jan 2005 [Full text]